These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7486804)

  • 1. Contribution of serum globulins to total fructosamine in patients treated by haemodialysis.
    Hutchesson AC; Smith JM
    Ann Clin Biochem; 1995 Jul; 32 ( Pt 4)():419-21. PubMed ID: 7486804
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of plasma fructosamine in non-diabetic and diabetic chronic renal failure].
    Delattre J; Rottembourg J; Thuillier-Juteau Y; Allouache A; Villiamier C; Jaudon MC; Galli A
    Presse Med; 1989 Nov; 18(36):1781-4. PubMed ID: 2530565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of fructosamine in hemodialysis patients].
    Küenburg E; Brunnbauer M; Watzinger U; Winter F; Müller MM; Graf H; Prager R
    Wien Klin Wochenschr Suppl; 1990; 180():11-3; discussion 32-3. PubMed ID: 2321384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fructosamines in uraemia and renal replacement therapy.
    Beardsworth SF; Vernon V; Harrison D
    Nephrol Dial Transplant; 1989; 4(8):748-9. PubMed ID: 2510086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of the metabolic condition in diabetics with renal insufficiency by means of the fructosamine test].
    Wagner R; Löwenstein I; Gieshoff B; Graben N; Olbricht T; Windeck R; Benker G; Reinwein D
    Dtsch Med Wochenschr; 1987 Jan; 112(5):175-7. PubMed ID: 3803236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of fructosamine in chronic kidney diseases (dialysis-dependent patients)].
    Peheim E; Descoeudres C; Diem P; Colombo JP; Vorberg E
    Wien Klin Wochenschr Suppl; 1990; 180():13-20; discussion 32-3. PubMed ID: 2321385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycated haemoglobin and fructosamine in non-diabetic subjects with chronic renal failure.
    Morgan LJ; Marenah CB; Morgan AG; Burden RP; John WG
    Nephrol Dial Transplant; 1990; 5(10):868-73. PubMed ID: 2128382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical availability of serum fructosamine measurement in diabetic patients with uremia. Use as a glycemic index in uremic diabetes.
    Shoji T; Tabata T; Nishizawa Y; Kikunami K; Matsushita Y; Inoue T; Kenmotsu M; Miki T; Morii H
    Nephron; 1989; 51(3):338-43. PubMed ID: 2918945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
    Emoto M; Tabata T; Inoue T; Nishizawa Y; Morii H
    Nephron; 1992; 61(2):181-6. PubMed ID: 1630543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [N-acetyl-beta-D-glucosaminidase activity in relation to blood glucose, serum fructosamine and type I diabetic nephropathy].
    Pinto C; Fernandes F; Marques C; Silva A; Azevedo M; Lisboa P; Manso C
    Acta Med Port; 1985; 6(3-4):97-102. PubMed ID: 4025000
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of hypoalbuminaemia, hyperbilirubinaemia and renal failure on serum fructosamine concentration in non-diabetic individuals.
    Dominiczak MH; Orrell JM; Finlay WE
    Clin Chim Acta; 1989 Jun; 182(2):123-9. PubMed ID: 2776348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone in patients with diabetes mellitus and end-stage renal disease on chronic haemodialysis.
    Pabico RC; Rivero AJ; McKenna BA; Freeman RB
    Proc Eur Dial Transplant Assoc; 1983; 19():221-6. PubMed ID: 6878235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood levels of chromium in diabetic and nondiabetic hemodialysis patients.
    Romero RA; Salgado O; Rodríguez-Iturbe B; Tahán JE
    Transplant Proc; 1996 Dec; 28(6):3382-4. PubMed ID: 8962320
    [No Abstract]   [Full Text] [Related]  

  • 14. Peritoneal dialysis for patients with diabetes and end-stage renal disease: sorting out the biases?
    Finkelstein FO; Smith JD
    ASAIO J; 1996; 42(1):1-3. PubMed ID: 8808447
    [No Abstract]   [Full Text] [Related]  

  • 15. Fructosamine concentration changes in serum during hemodialysis of kidney-disease patients.
    Brighton MW; Furth AJ
    Clin Chem; 1988 Nov; 34(11):2378-9. PubMed ID: 3180447
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of serum albumin & total protein on fructosamine measurement.
    Das BS; Satpathy SK; Mohanty S; Bose TK
    Indian J Med Res; 1992 Feb; 96():60-4. PubMed ID: 1597333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipoprotein(a) levels in patients having chronic renal failure with and without diabetes mellitus.
    Makino K; Josephson MA; Fellner SK; Scanu AM
    Atherosclerosis; 1993 Jan; 98(2):255-6. PubMed ID: 8457265
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in serum ionized and total magnesium values during chronic renal failure between nondiabetic and diabetic patients: a cross-sectional study.
    Dewitte K; Dhondt A; Giri M; Stöckl D; Rottiers R; Lameire N; Thienpont LM
    Diabetes Care; 2004 Oct; 27(10):2503-5. PubMed ID: 15451927
    [No Abstract]   [Full Text] [Related]  

  • 19. Intraperitoneal administration of insulin during peritoneal dialysis of diabetic patients with terminal renal failure.
    Andersen KE; Petersen PH
    Proc Eur Dial Transplant Assoc; 1981; 18():206-11. PubMed ID: 7036148
    [No Abstract]   [Full Text] [Related]  

  • 20. [Management of blood glucose in diabetic dialysis patients].
    Hori K; Fujimi S
    Nihon Rinsho; 1992 Jan; 50 Suppl():192-6. PubMed ID: 1578677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.